Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases)

Elisa Gremese, Barbara Tolusso, Maria Rita Gigante, Gianfranco Ferraccioli

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

70 Citazioni (Scopus)


The growing body of evidence recognizing the adipose tissue (AT) as an active endocrine organ secreting bioactive mediators involved in metabolic and inflammatory disorders, together with the global epidemic of overweight and obesity, rise obesity as a hot topic of current research. The chronic state of low-grade inflammation present in the obese condition and the multiple pleiotropic effects of adipokines on the immune system has been implicated in the pathogenesis of several inflammatory conditions including rheumatic autoimmune and inflammatory diseases. We will discuss the main relevant evidences on the role of the AT on immune and inflammatory networks and the more recent evidences regarding the effects of obesity on the incidence and outcomes of the major autoimmune chronic inflammatory diseases.
Lingua originaleEnglish
pagine (da-a)576-576
Numero di pagine1
RivistaFrontiers in Immunology
Stato di pubblicazionePubblicato - 2014


  • adipokines
  • body mass index
  • inflammation
  • obesity
  • rheumatic diseases
  • rheumatoid arthritis


Entra nei temi di ricerca di 'Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases)'. Insieme formano una fingerprint unica.

Cita questo